NextPlat (NXPL) Shares Outstanding (2010 - 2026)
NextPlat's (NXPL) quarterly Shares Outstanding (Entity) came in at $2.7 million in Q2 2026, up 4.5% year-over-year from $2.6 million in Q2 2025, and little changed quarter-over-quarter from $2.7 million in Q1 2026.
Analysis
NextPlat (NXPL) Shares Outstanding (2010 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Shares Outstanding (Entity) for 17 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 4.5% year-over-year to $2.7 million in Q2 2026; TTM through Jun 2026 was $2.7 million, a 4.5% increase from a year earlier, with the FY2025 full-year figure at $2.7 million, up 29.85% from the prior year.
- Shares Outstanding (Entity) was $2.7 million for Q2 2026 at NextPlat, roughly flat from $2.7 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $2.7 million in Q2 2026 and troughed at $929310.0 in Q1 2022.
- A 5-year average of $1.9 million and a median of $1.9 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) jumped 843.23% in 2022 and increased 1.43% in 2024, its largest moves.
- Over 5 years, Shares Outstanding (Entity) stood at $962959.0 in 2022, then soared by 94.45% to $1.9 million in 2023, then gained by 10.09% to $2.1 million in 2024, then climbed by 29.85% to $2.7 million in 2025, then increased by 1.36% to $2.7 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $2.7 million (Q2 2026), $2.7 million (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 1.17 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 1.16 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 832.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 319.20 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 375.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 21.16 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 289.73 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 43.64 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 34.55 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 2.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.71 Mn |
| Mar 31, 2026 | 2.69 Mn |
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 2.60 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Sep 30, 2023 | 1.87 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 962,959.00 |
| Sep 30, 2022 | 946,951.00 |
| Jun 30, 2022 | 929,310.00 |
| Mar 31, 2022 | 916,688.00 |
| Dec 31, 2021 | 408,083.00 |
| Sep 30, 2021 | 629,031.00 |